Analabs Resources Berhad

KLSE:ANALABS Stock Report

Market Cap: RM 205.9m

Analabs Resources Berhad Balance Sheet Health

Financial Health criteria checks 3/6

Analabs Resources Berhad has a total shareholder equity of MYR468.4M and total debt of MYR183.0M, which brings its debt-to-equity ratio to 39.1%. Its total assets and total liabilities are MYR689.4M and MYR221.0M respectively. Analabs Resources Berhad's EBIT is MYR36.9M making its interest coverage ratio -295.5. It has cash and short-term investments of MYR20.2M.

Key information

39.1%

Debt to equity ratio

RM 183.03m

Debt

Interest coverage ratio-295.5x
CashRM 20.18m
EquityRM 468.44m
Total liabilitiesRM 220.96m
Total assetsRM 689.40m

Recent financial health updates

Recent updates

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Jan 04
Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Feb 13
Analabs Resources Berhad (KLSE:ANALABS) Is Due To Pay A Dividend Of MYR0.02

Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Mar 28
Analabs Resources Berhad (KLSE:ANALABS) Is Doing The Right Things To Multiply Its Share Price

Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Jan 21
Analabs Resources Berhad (KLSE:ANALABS) Has A Pretty Healthy Balance Sheet

Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Sep 13
Here's Why Analabs Resources Berhad (KLSE:ANALABS) Can Manage Its Debt Responsibly

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

May 24
Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Apr 28
Analabs Resources Berhad (KLSE:ANALABS) Might Be Having Difficulty Using Its Capital Effectively

Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Apr 07
Here's Why We Think Analabs Resources Berhad (KLSE:ANALABS) Is Well Worth Watching

Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

Mar 17
Could Analabs Resources Berhad (KLSE:ANALABS) Have The Makings Of Another Dividend Aristocrat?

Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Feb 19
Should You Buy Analabs Resources Berhad (KLSE:ANALABS) For Its Upcoming Dividend?

Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Feb 09
Does Analabs Resources Berhad (KLSE:ANALABS) Have A Healthy Balance Sheet?

Is Analabs Resources Berhad (KLSE:ANALABS) Set To Make A Turnaround?

Jan 14
Is Analabs Resources Berhad (KLSE:ANALABS) Set To Make A Turnaround?

Is Analabs Resources Berhad (KLSE:ANALABS) An Attractive Dividend Stock?

Dec 07
Is Analabs Resources Berhad (KLSE:ANALABS) An Attractive Dividend Stock?

Financial Position Analysis

Short Term Liabilities: ANALABS's short term assets (MYR69.5M) do not cover its short term liabilities (MYR185.9M).

Long Term Liabilities: ANALABS's short term assets (MYR69.5M) exceed its long term liabilities (MYR35.1M).


Debt to Equity History and Analysis

Debt Level: ANALABS's net debt to equity ratio (34.8%) is considered satisfactory.

Reducing Debt: ANALABS's debt to equity ratio has increased from 9.9% to 39.1% over the past 5 years.

Debt Coverage: ANALABS's debt is not well covered by operating cash flow (12.4%).

Interest Coverage: ANALABS earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies